TABLE 1

Patient Characteristics and Dipyridamole-Induced Hemodynamic Changes of Study Groups

CharacteristicSubgroup 1 (n = 34)Subgroup 2 (n = 28)PTotal group (n = 62)
Mean age ± SD (y)47 ± 752 ± 100.03949 ± 9
Mean BMI ± SD (kg/m2)35 ± 1232 ± 70.23934 ± 10
Women (n)31 (91%)22 (79%)0.16153 (85%)
African Americans (n)30 (88%)24 (86%)0.95854 (87%)
Hypertension (n)22 (65%)18 (64%)0.97340 (65%)
Smoking (n)18 (53%)9 (32%)0.10027 (44%)
Dyslipidemia (n)13 (38%)11 (39%)0.93324 (39%)
Diabetes (n)7 (21%)10 (36%)0.18417 (27%)
Mean baseline heart rate ± SD (bpm)68 ± 1164 ± 90.13167 ± 10
Mean peak heart rate ± SD (bpm)97 ± 1488 ± 100.00793 ± 13
Mean heart rate change ± SD (bpm)28 ± 1023 ± 110.06326 ± 11
Mean baseline arterial pressure ± SD (mm Hg)97 ± 1296 ± 150.89697 ± 13
Mean nadir arterial pressure ± SD (mm Hg)91 ± 1189 ± 150.55890 ± 13
Mean arterial pressure change ± SD (mm Hg)6 ± 610 ± 170.1398 ± 12
  • BMI = body mass index; bpm = beat per minute.